11:48 AM EST - Abcann Global Corporation : Has completed the acquisition of Harvest Medicine Inc. pursuant to the terms of a share purchase agreement dated January 31, 2018, in consideration for, among other things, a cash payment of $1.5 million; the issuance of 1,056,338 common shares in the capital of the Company; and additional post-closing consideration if certain performance milestones, which include certain patient, revenue and profitability metrics, are achieved. ABcann Global Corporation
shares V.ABCN are trading down $0.13 at $2.95.
